glipizide has been researched along with Leukemia, Lymphoid in 1 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordera, R | 1 |
| Chimini, G | 1 |
| Bagnasco, M | 1 |
| Gherzi, R | 1 |
1 other study available for glipizide and Leukemia, Lymphoid
| Article | Year |
|---|---|
Insulin binding on MOLT 4 cells: effect of a sulfonylurea.
Topics: Cell Line; Glipizide; Humans; Insulin; Kinetics; Leukemia, Lymphoid; Receptor, Insulin; Sulfonylurea | 1984 |